至本医疗科技是一家科技转化型公司,专注于高新技术的研发以及临床应用的转化,宗旨是让每一个癌症患者在临床上得到最大可能的实际获益。通过国际化和标准化的质控平台,运用高通量二代测序检测技术为代表的先进技术,全面检测所有与癌症治疗密切相关的基因异常信息,致力于为每一位患者提供个性化的医疗咨询服务。

The OrigiMed is a science and technology transforming company which focuses on developing new technologies and clinical translation for all cancer patients across China. By carrying out comprehensive detection via next generation high-throughput sequencing technologies, we provide personalized treatment options and consulting services for each individual cancer patient. We hold ourselves to a high-level of excellence, striving to create the maximum benefit for patients under the international standardization and quality control system.